Definitive Healthcareの空売り状況は、投資家がDefinitive Healthcareの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Definitive Healthcare (NASDAQ:DH) 株価情報, 空売り情報

DEFINITIVE HEALTHCARE CORP

Definitive Healthcare

Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.

Movers

Trading Ideas

BIMI

DALN

FFIE

FGEN

GRPN

JTAI

LMND

MGNX

NUZE

PITA

PMEC

POWL

TBIO

TIVC

アドバンスト マイクロ デバイセズ社 (NASDAQ:AMD) の株は、予想を上回る第2四半期決算を受けて本日のプレマーケット取引で急騰している。

AMD株価上昇　決算を受けて

Definitive Healthcare Corp. - Class A Common Stock

Definitive Healthcare Corp

DIGITAL HEALTH ACQUISITION CORP UNIT 1 COM & 1 WT EXP

DIH Holding US, Inc. - Class A Common Stock

DIH Holding US Inc

DAIWA HSE ASSET MGMT ASIA by DAIWA HSE ASSET MGMT ASIA PTE LTD.

Daiwa House Logistics Trust

Delivra Health Brands Inc

DELIVRA HEALTH BRANDS INC by DELIVRA HEALTH BRANDS INC.

Diversified Healthcare Trust - Common Shares of Beneficial Interest

Diversified Healthcare Trust

DHC ACQUISITION CORP UNIT 1 CL A & 1/3 WT EXP

DIAMONDHEAD CASINO CORP by Diamondhead Casino Corp.

Diamondhead Casino Corp

DATA HORIZON CO LTD by DATA HORIZON CO LTD.

Diversified Healthcare Trust - 5.625% Senior Notes due 2042

Diversified Healthcare Trust - 6.25% Senior Notes Due 2046

First Trust Exchange-Traded Fund VIII FT Vest U.S. Equity Quarterly 2.5 to 15 Buffer ETF

BNY Mellon High Yield Strategies Fund Common Stock

BNY Mellon High Yield Strategies Fund

DOMAIN HLDGS AUSTRAIA LTD by DOMAIN HLDGS AUSTRALIA LTD.

Domain Holdings Australia Ltd

DESARROLLADORA HOM SA ORD by Desarrolladora Homex SA de CV

Desarrolladora Homex SAB de CV

D.R. Horton Inc

Diamond Hill Investment Group, Inc. - Class A Common Stock

Diamond Hill Investment Group Inc

GLOBAL STRATEGIC GROUP by Global Strategic Group Ltd

Global Strategic Group Ltd

DEUTSCHE POST AG S/ADR by Deutsche Post AG

Deutsche Post AG

Danaher Corp

DEUTSCHE EUROSHOP UNS/ADR by Deutsche Euroshop AG

Deutsche EuroShop AG

WisdomTree U.S. High Dividend Fund

Strategy Shares Day Hagan Smart Buffer ETF

DAH SING BANKING GRP ORD by Dah Sing Banking Group Ltd.

Dah Sing Banking Group Ltd

DHT Holdings Inc

dHedge DAO

DRI Healthcare Trust

DHI Group Inc

Credit Suisse High Yield Bond Fund Common Stock

Credit Suisse High Yield Bond Fund

MercadoLibre, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MELI#NASDAQ">MELI</a>) is little changed Thursday. The stock has been in a downtrend, and there is a good chance it will continue to move lower. The stock has broken support around $1,945, and this can be a bearish dynamic.
Our team of technical analysts has made it our Stock of the Day.
Support is a price level or range where there is a significant amount of buy interest. There is as many, or maybe even more, shares to be bought as there are to be sold. This is why downtrends end or pause when they reach support.
You can see on the chart that the $1,945 level was support in early March.
Sometimes stocks reverse and rally after reaching support, like MercadoLibre did then. This happens when some of the buyers who created to support raise their bid prices to get ahead of other buyers. This can lead to a snowball effect as other buyers do the same. This forces the stock higher.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="525" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03131350/MercadoLibre-1024x525.png" alt="" class="wp-image-856124" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03131350/MercadoLibre-1024x525.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03131350/MercadoLibre-300x154.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03131350/MercadoLibre-768x394.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03131350/MercadoLibre-1536x787.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03131350/MercadoLibre.png 1617w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read Also: <a href="https://www.benzinga.com/news/25/04/44630931/commerce-secretary-lutnick-says-us-markets-will-perform-extremely-well-long-term-despite-trump-tariff-selloff">Commerce Secretary Lutnick Says US Markets Will Perform &#8216;Extremely Well&#8217; Long Term Despite Trump Tariff Selloff</a>
But sometimes when a stock reaches support, the sellers eventually overpower the buyers and push the price lower. When this happens, traders say the support has ‘broken.' This just happened with MercadoLibre.
This isn't merely symbolic. It illustrates an important dynamic. It shows that the traders and investors who created the support with their buy orders have either finished or canceled them.
With this large amount of demand taken out of the market, the stage could be set for a move lower. People who wish to sell will be forced to be aggressive and push the stock down if they want to draw buyers back into the market.
If MercadoLibre trends lower, there is a good chance the next support level will be around the $1,800 level. This level was support in January, and there tends to be support at levels that previously had been support.
There are people who sold their shares at the support that regretted doing so when the price rallied after. Some of them vowed to buy their shares back if they could eventually get them at the same price they were sold.
So, if the stock reaches the $1,800 level they will place buy orders. If there are enough of them, it will create support at the level again.
At this point, some traders would consider buying. They will be expecting a rally off the support.
Read Next: • <a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44626421/trumps-reign-of-tariffs-unleashes-d-day-on-wall-street-analyst-warns-of-stagflation-risk">Trump&#8217;s &#8216;Reign Of Tariffs&#8217; Unleashes &#8216;D-Day On Wall Street,&#8217; Analyst Warns Of Stagflation Risk</a>
Photo: T. Schneider via Shutterstock

Technicals

MELI

Stock Of The Day: Where Will The MercadoLibre Sell-Off End?

WIIM

Shares of major Europe-related ETFs are trading lower as markets react to President Trump's announcement of sweeping tariffs.

News

AMZN

Amazon Says Testing New Feature, Buy For Me, In Beta In Amazon Shopping App - Website

Federal Reserve

Fed's Jefferson Says Still Substantial Uncertainty Around Trade; Says Uncertainty Can Weigh On Spending, Investment Decisions; Says Will Be Important To Take Our Time And Think About Impact

HC Wainwright &amp; Co. analyst Patrick Trucchio reiterates Altimmune (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALT#NASDAQ">ALT</a>) with a Buy and maintains $12 price target.

Price Target

Reiteration

Analyst Ratings

HC Wainwright & Co. Reiterates Buy on Altimmune, Maintains $12 Price Target

AVGO

KLAC

LRCX

LSCC

NXPI

Shares of chip stocks are trading lower as markets react to President Trump's announcement of sweeping tariffs.

<h3>Gainers</h3>
<ul>
<li>Creative Global Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGTL#NASDAQ">CGTL</a>) shares moved upwards by 26.5% to $5.25 during Thursday's regular session. The market value of their outstanding shares is at $112.5 million. </li>
<li>Digital Ally (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DGLY#NASDAQ">DGLY</a>) stock rose 9.08% to $0.04. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Vishay Precision Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VPG#NYSE">VPG</a>) stock decreased by 22.3% to $21.94 during Thursday's regular session. The company's market cap stands at $290.8 million. </li>
<li>CommScope Holding Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COMM#NASDAQ">COMM</a>) shares fell 22.27% to $4.19. The company's market cap stands at $907.3 million. </li>
<li>Soluna Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNH#NASDAQ">SLNH</a>) stock fell 21.09% to $0.44. The market value of their outstanding shares is at $4.6 million. As per the news, the Q4 earnings report came out 2 days ago. </li>
<li>SiTime (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SITM#NASDAQ">SITM</a>) stock fell 19.38% to $127.61. The market value of their outstanding shares is at $3.0 billion. </li>
<li>Sagtec Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAGT#NASDAQ">SAGT</a>) shares decreased by 19.27% to $2.31. The market value of their outstanding shares is at $28.9 million. </li>
<li>Turtle Beach (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBCH#NASDAQ">TBCH</a>) shares decreased by 18.63% to $12.26. The company's market cap stands at $244.7 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CGTL

COMM

DGLY

SAGT

SITM

SLNH

TBCH

8 Information Technology Stocks Moving In Thursday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Protagenic Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTIX#NASDAQ">PTIX</a>) shares rose 85.8% to $0.42 during Thursday's regular session. The market value of their outstanding shares is at $3.0 million. As per the news, the Q4 earnings report came out 3 days ago. </li>
<li>OSR Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OSRH#NASDAQ">OSRH</a>) shares moved upwards by 59.18% to $2.34. The market value of their outstanding shares is at $45.1 million. </li>
<li>Aptevo Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APVO#NASDAQ">APVO</a>) shares rose 45.67% to $2.01. The company's market cap stands at $2.9 million. </li>
<li>Alaunos Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCRT#NASDAQ">TCRT</a>) shares rose 38.75% to $3.88. The market value of their outstanding shares is at $6.2 million. </li>
<li>Genprex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNPX#NASDAQ">GNPX</a>) shares moved upwards by 31.33% to $0.39. The market value of their outstanding shares is at $3.2 million. </li>
<li>Tivic Health Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIVC#NASDAQ">TIVC</a>) shares increased by 30.76% to $4.25. The company's market cap stands at $2.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Aldeyra Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALDX#NASDAQ">ALDX</a>) stock declined by 73.7% to $1.4 during Thursday's regular session. The company's market cap stands at $83.3 million. </li>
<li>Virpax Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRPX#NASDAQ">VRPX</a>) shares decreased by 61.61% to $0.47. </li>
<li>RxSight (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXST#NASDAQ">RXST</a>) stock fell 39.29% to $15.86. The market value of their outstanding shares is at $642.1 million. </li>
<li>Impact BioMedical (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/IBO#AMEX">IBO</a>) stock decreased by 18.3% to $0.47. The market value of their outstanding shares is at $5.3 million. </li>
<li>CervoMed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRVO#NASDAQ">CRVO</a>) shares decreased by 17.75% to $11.17. The market value of their outstanding shares is at $97.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALDX

APVO

CRVO

GNPX

OSRH

PTIX

RXST

TCRT

VRPX

11 Health Care Stocks Moving In Thursday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>MEDIROM Healthcare Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRM#NASDAQ">MRM</a>) shares moved upwards by 36.5% to $0.51 during Thursday's regular session. The market value of their outstanding shares is at $3.9 million. </li>
<li>Forward Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORD#NASDAQ">FORD</a>) shares moved upwards by 28.12% to $5.74. The market value of their outstanding shares is at $6.3 million. </li>
<li>Springview Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPHL#NASDAQ">SPHL</a>) stock increased by 25.89% to $0.53. The market value of their outstanding shares is at $6.0 million. </li>
<li>Damon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DMN#NASDAQ">DMN</a>) stock rose 18.11% to $0.02. The market value of their outstanding shares is at $2.5 million. </li>
<li>Algorhythm Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIME#NASDAQ">RIME</a>) stock increased by 17.11% to $2.48. The company's market cap stands at $5.9 million. </li>
<li>Goodyear Tire &amp; Rubber (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GT#NASDAQ">GT</a>) shares increased by 12.54% to $10.26. The market value of their outstanding shares is at $2.9 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>RH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RH#NYSE">RH</a>) stock fell 39.6% to $150.51 during Thursday's regular session. The company's market cap stands at $2.8 billion. As per the press release, Q4 earnings came out yesterday. </li>
<li>VF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VFC#NYSE">VFC</a>) stock fell 27.92% to $11.81. The company's market cap stands at $4.6 billion. </li>
<li>Capri Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPRI#NYSE">CPRI</a>) stock declined by 27.36% to $14.26. The company's market cap stands at $1.6 billion. </li>
<li>Wayfair (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/W#NYSE">W</a>) shares fell 27.29% to $24.52. The market value of their outstanding shares is at $3.1 billion. </li>
<li>Five Below (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVE#NASDAQ">FIVE</a>) shares fell 26.09% to $60.23. The market value of their outstanding shares is at $3.3 billion. </li>
<li>Kohl's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KSS#NYSE">KSS</a>) shares decreased by 22.84% to $6.64. The market value of their outstanding shares is at $738.7 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CPRI

FIVE

FORD

RIME

SPHL

12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Jayud Global Logistics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JYD#NASDAQ">JYD</a>) stock rose 47.6% to $0.51 during Thursday's regular session. The company's market cap stands at $48.7 million. </li>
<li>Li Bang International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LBGJ#NASDAQ">LBGJ</a>) stock increased by 24.07% to $1.34. The market value of their outstanding shares is at $25.1 million. </li>
<li>BioNexus Gene Lab (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGLC#NASDAQ">BGLC</a>) stock increased by 19.08% to $0.3. The company's market cap stands at $5.4 million. </li>
<li>Addentax Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATXG#NASDAQ">ATXG</a>) shares moved upwards by 14.14% to $0.88. The company's market cap stands at $5.3 million. </li>
<li>Click Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLIK#NASDAQ">CLIK</a>) shares increased by 13.3% to $2.64. The company's market cap stands at $39.3 million. </li>
<li>Galaxy Payroll Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLXG#NASDAQ">GLXG</a>) stock rose 12.87% to $0.74. The market value of their outstanding shares is at $13.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>1847 Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/EFSH#AMEX">EFSH</a>) stock decreased by 40.3% to $0.07 during Thursday's regular session. The market value of their outstanding shares is at $1.8 million. </li>
<li>American Rebel Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AREB#NASDAQ">AREB</a>) shares fell 34.19% to $4.14. The market value of their outstanding shares is at $2.4 million. </li>
<li>Baiya International Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIYA#NASDAQ">BIYA</a>) shares declined by 33.91% to $3.43. The market value of their outstanding shares is at $42.8 million. </li>
<li>Franklin Covey (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FC#NYSE">FC</a>) stock declined by 24.46% to $21.07. The market value of their outstanding shares is at $278.0 million. As per the news, the Q2 earnings report came out yesterday. </li>
<li>Forward Air (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWRD#NASDAQ">FWRD</a>) stock fell 23.39% to $15.89. The company's market cap stands at $483.1 million. </li>
<li>Zoomcar Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZCAR#NASDAQ">ZCAR</a>) stock declined by 21.07% to $3.9. The company's market cap stands at $2.6 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AREB

ATXG

BGLC

BIYA

CLIK

EFSH

FWRD

GLXG

LBGJ

ZCAR

12 Industrials Stocks Moving In Thursday's Intraday Session

AMGN

KNSL

SBRA

CNBC Halftime Report Final Trades: Amgen, Kinsale Capital Group, Sabra Health Care REIT

Ford Motor Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) has experienced significant fluctuations in its share price related to tariff announcements in recent months. Ford shares are falling again Thursday as auto tariffs <a href="https://www.benzinga.com/markets/25/03/44509009/over-7-million-vehicles-could-face-the-brunt-of-trumps-auto-tariffs-this-could-drive-the-auto-industry-into-recession">go into effect</a>.
A Look Back: In February, President Donald Trump imposed a 25% tariff on imports from Canada and Mexico and a 10% tariff <a href="https://www.spglobal.com/automotive-insights/en/rapid-impact-analysis/us-auto-tariffs-disruption-hits-north-american-industry?utm_source=chatgpt.com">on Chinese goods.</a> The tariffs on Canada and Mexico were temporarily reversed following negotiations.
By early March, the Trump administration signaled that the 25% tariff on Canada and Mexico would be reinstated, and Chinese imports would face an additional 10% tariff. 
After discussions with executives from Ford, General Motors Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) and Stellantis N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STLA#NYSE">STLA</a>), Trump allowed for a temporary exemption for United States-Mexico-Canada Agreement (USMCA)-compliant goods.
What&#8217;s Going On: A 25% tariff on all imported vehicles and key parts went into effect on Thursday. Vehicles compliant with the USMCA are only subject to tariffs on <a href="https://www.usatoday.com/story/money/cars/2025/03/31/when-auto-tariffs-trump-2025/82739633007/">foreign-sourced parts</a> used in manufacturing. At the same time, Trump has introduced a broad set of reciprocal tariffs targeting several countries.
Ford's stock has faced significant volatility in recent months, with investors struggling to predict the Trump administration's next moves. The recent implementation of tariffs is expected to raise costs for Ford, which could squeeze profit margins and potentially lead to higher prices for consumers.
See Also: <a href="https://www.benzinga.com/trading-ideas/movers/25/04/44629761/whats-going-on-with-rh-shares-thursday">What&#8217;s Going On With RH Shares Thursday?</a>
F Price Action: At the time of publication, Ford shares were down 4.29% at $9.71, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro.</a>
Image via Shutterstock

Government

STLA

Ford Stock Falls As Auto Tariffs Take Effect: What's Going On?

In the current session, Asbury Automotive Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABG#NYSE">ABG</a>) is trading at $219.00, after a 5.11% decrease. Over the past month, the stock decreased by 16.26%, and in the past year, by 3.88%. With performance like this, long-term shareholders are more likely to start looking into the company's price-to-earnings ratio. 

<img src="https://www.benzinga.com/files/images/story/2025/1743699623_0.png" alt="Past Year Chart" />

<h3>Asbury Automotive Group P/E Ratio Analysis in Relation to Industry Peers</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of the 27.33 in the Specialty Retail industry, Asbury Automotive Group Inc. has a lower P/E ratio of 10.73. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1743699623_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Markets

P/E Ratio Insights for Asbury Automotive Group

Economic Headwinds: Trade Tensions and Slowing Growth
The U.S. economy faces mounting challenges as new tariffs take effect, with concerns over inflation, rising unemployment, and weakening growth. Goldman Sachs projects a slowdown, with recession risks increasing in the coming months. Meanwhile, Federal Reserve officials acknowledge the uncertainty ahead, with Federal Reserve Bank of New York President John Williams stating, "I expect the economy will continue to grow, but slower than last year."
Don't Miss:
<ul>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>
<li>If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/money/arrived-private-credit-fund">7-9% target yield with monthly dividends would you invest in it</a>?</li>
</ul>
Inflation and Interest Rate Adjustments
Inflation remains above the Fed's 2% target, with forecasts suggesting it could reach 3.5% in 2025. As a result, the Fed is expected to cut interest rates three times this year to support the economy, an adjustment from earlier projections of two cuts. However, questions remain about whether these cuts will be sufficient to offset broader economic headwinds, "as people at all income levels worry they will be worse off in a year."
Trade Policy Uncertainty
Trump's proposed tariffs, potentially as high as 20% on key trading partners, could further disrupt global markets and add pressure to economic growth. While exclusions may soften the impact, businesses and consumers are bracing for the effects of prolonged trade tensions.
Bitcoin's Role in a Shifting Economy
Bitcoin is currently down roughly 25% from its all-time high of $110,000 per BTC. This decline follows a more than 10% drop in the S&amp;P 500 from its highs.
The last time the S&amp;P 500 fell more than 10% from its all-time highs was in early 2022, after inflation began rising in early 2021. By the time the S&amp;P 500 was down 10%, Bitcoin had already fallen over 50%!
Trending: It&#8217;s no wonder Jeff Bezos holds over $250 million in art — <a href="https://www.benzinga.com/money/masterworks">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</a>
Bitcoin has historically demonstrated volatility within the financial markets. While it still possesses these characteristics today, its role has evolved alongside the broader economy.
In recent times, Bitcoin has established itself as a trusted currency used in trade. Recently, Russia began utilizing Bitcoin in oil transactions with China, and it is expected to continue being adopted by other countries that lack the currency power of the U.S. and similar nations.
With the increased fundamental use of Bitcoin, the currency has maintained strength even during recent downward movements in U.S. equities.
Key Levels to Watch
At the end of the day, Bitcoin is not immune to downside movements. As discussed, it has recently faced downward pressure despite bullish catalysts due to macroeconomic concerns.
This can be observed when looking at Bitcoin&#8217;s ETF inflows vs. outflows, which shows that the total cumulative flow has decreased since early February.
When analyzing key levels for Bitcoin, it is crucial to understand the market&#8217;s current structure and the narrative behind certain levels. One major level with significant narrative importance is the low that was printed on the charts just before the U.S. election. Currently, Bitcoin is trading 23% above this election low, whereas both the S&amp;P and Nasdaq are trading below their respective election lows.
See Also: This platform is reshaping how you invest in private companies —<a href="https://www.benzinga.com/money/kingscrowd-adv"> and you can be a part of it for $0.18 per share</a>
This highlights Bitcoin&#8217;s relative strength compared to the U.S. stock market, even amid economic uncertainty. However, it is also a key level that Bitcoin should remain above if higher prices are to be seen in the coming weeks and months.
The next level traders and investors should watch is the 50% retracement of the weekly trading range. This is shown on the chart above, measured from the swing low formed before the expansion toward $100,000 to the high that formed during Trump&#8217;s inauguration.
This price level is $79,446.5, a short-term level for Bitcoin to hold on the weekly chart. If this level breaks, it could signal a potential breakdown of the 50 EMA, which may then lead to a move toward the election low of $66,810.0.
When analyzing Bitcoin on lower time frames, you may encounter more noise. However, there are key levels to watch that could provide a short-term outlook, especially if bullish reactions begin to emerge.
As you zoom into the daily chart, you gain more detail. Here, we can see the election low more clearly, which formed just before the U.S. election. This is the level, as mentioned, that you&#8217;d want to see Bitcoin stay above to maintain the potential HTF bullish trend.
Within the HTF range, there are two major support zones to monitor. The first is the area where BTC initially bounced, which aligns with the 50% retracement level on the weekly chart. The second is the low 80-82k range, where Bitcoin is currently trading.
The best-case scenario, similar to the bounce seen in stock indices to start the week, would be for Bitcoin to hold the first support range and potentially continue short-term, moving back up to the previous swing high, which is around $88,000.
The worst-case scenario is that the stock market continues its bearish trend, and Bitcoin starts to make its way down to the election low.
Bull or Bear?
Bitcoin has shown more strength recently during the downturn the stock market has experienced over the last two months.
Based on that strength and the current structure of Bitcoin, along with positive fundamentals, Bitcoin still appears to have a strong bullish case, even amid uncertainty. However, the key levels discussed will be crucial to monitor as they will serve as a guide.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
</ul>

Personal Finance

Bitcoin's First Real Test in an Uncertain Economy: Key Levels to Watch Amid Tariff Pressures

BABA

BILI

New Oriental Education & Technology Group

GSX Techedu Inc. American Depositary Shares

GOTU

HTHT

Citigourp Global Markets 2% Protected Notes Linked To The Djia

TCOM

VIPS

Shares of US-listed Chinese companies are trading lower as markets react to President Trump's announcement of sweeping tariffs.

Editor&#8217;s Note: The story has been updated with comments from Novavax
In September 2024, the U.S. Food And Drug Administration (FDA) granted Emergency Use Authorization to Novavax Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV2705) for active immunization to prevent COVID-19 in <a href="https://www.benzinga.com/general/biotech/24/09/40688052/fda-approves-novavaxs-updated-covid-vaccine-targeting-currently-circulating-variants" target="_blank" rel="noreferrer noopener">individuals aged 12 and older</a>.
Novavax's vaccine was included in the recommendations issued by the U.S. Centers for Disease Control and Prevention (CDC) on&nbsp;June 27, 2024.
Also Read: <a target="_blank" href="https://www.benzinga.com/24/12/42323263/wegovy-maker-novo-nordisk-to-buy-novavaxs-czech-republic-manufacturing-facility-for-200-million" rel="noreferrer noopener">Wegovy Maker Novo Nordisk To Buy Novavax&#8217;s Czech Republic Manufacturing Facility For $200 Million</a>
According to a media report on Wednesday, the regulators missed the deadline for deciding to grant full approval to Novavax's shot.
In an emailed statement to Benzinga, Novavax said, &#8220;Novavax can confirm that April 1, 2025, was the U.S. Food and Drug Administration (FDA)'s Prescription Drug User Fee Act date for our Biologics License Application (BLA) seeking the approval of our COVID-19 Vaccine. As of Tuesday, April 1, we had responded to all of the FDA's information requests and we believe that our BLA is ready for approval. 
As of today, we continue to wait on action from the agency and have not yet received an official decision from the U.S. FDA. Our application included robust Phase 3 clinical trial data that showed our vaccine is safe and effective for the prevention of COVID-19. We are confident our well-tolerated vaccine represents an important alternative to mRNA COVID-19 vaccines for the U.S.&#8221;
Earlier this week, Peter Marks&nbsp;resigned from his role at the FDA's Center for Biologics Evaluation and Research.
Marks was a top regulator at the FDA and played a key role in pushing quick approvals of vaccines <a href="https://www.benzinga.com/25/03/44562368/moderna-novavax-shares-are-tumbling-monday-whats-going-on" target="_blank" rel="noreferrer noopener">during the COVID-19 pandemic</a>.
The Wall Street Journal <a href="https://www.wsj.com/health/healthcare/fda-novavax-covid-19-vaccine-deadline-c160454b" target="_blank" rel="noreferrer noopener">writes</a> that the agency is now delaying the decision and has reportedly asked for more data and that the application isn't likely to be approved soon, according to sources.
The FDA set an April 1 deadline for a decision.
Novavax reported fourth-quarter 2024 sales of $88.31 million, compared to&nbsp;$291 million&nbsp;a year, beating the&nbsp;consensus of $84.35 million. The decrease was due to lower product sales <a target="_blank" href="https://www.benzinga.com/general/biotech/25/02/44013531/novavax-reports-smaller-q4-loss-shifts-focus-from-commercializing-covid-19-vaccine-to-maximize-value" rel="noreferrer noopener">under APA agreements</a>.
The COVID-19 vaccine maker reported an earning loss of 51 cents per share, down from $1.44 a year ago, in line&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/n44004179/novavax-reports-fourth-quarter-and-full-year-2024-financial-results-and-operational-highlights" rel="noreferrer noopener">with the Wall Street Estimate</a>.
The news comes after vaccine stocks came under pressure last week following reports that the Trump administration plans to end financial support for vaccine alliance Gavi, which helps buy vaccines for children in developing countries. The Trump administration reportedly plans to cut billions in global health initiatives.
Price Action: NVAX stock is up 1.25% at $6.09 at the last check on Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/25/04/44610702/edgewise-therapeutics-sees-meaningful-hcm-treatment-gains-with-edg-7500-in-phase-2-study" target="_blank" rel="noreferrer noopener">Edgewise Therapeutics Sees Meaningful HCM Treatment Gains With EDG-7500 In Phase 2 Study</a></li>
</ul>
Photo: Shutterstock

Biotech

Health Care

Rumors

General

NVAX

FDA Delays Full Approval Decision On Novavax's COVID-19 Vaccine (UPDATED)

CPNG

Live On CNBC: Brad Gerstner Buys Coupang

President Donald Trump's sweeping new trade tariffs sent shockwaves through global markets on Thursday, triggering a massive sell-off that echoed the COVID-19 pandemic-era routs, as investor risk <a href="https://www.benzinga.com/markets">appetite vanished in a flash.</a>
Wall Street saw a staggering $2 trillion in market cap erased, with the U.S.&#8217;s biggest 10 companies shedding $1 trillion alone.
Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) plunged 8.7%, staring down its worst day since March 2020 and wiping out nearly $300 billion in value. NVIDIA Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) tumbled 6.4%, losing $171.9 billion, while Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) dropped 8%, on pace for a $166 billion hit.
<figure class="wp-block-table is-style-stripes"> 
<table>
<thead>
<tr>
<th>Company</th>
<th>% Daily Change</th>
<th>Market Cap Loss ($B)</th>
</tr>
</thead>
<tbody>
<tr>
<td>Apple</td>
<td>-8.74%</td>
<td>-293.95</td>
</tr>
<tr>
<td>NVIDIA</td>
<td>-6.38%</td>
<td>-171.89</td>
</tr>
<tr>
<td>Amazon</td>
<td>-8.03%</td>
<td>-166.80</td>
</tr>
<tr>
<td>Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>)</td>
<td>-6.64%</td>
<td>-98.24</td>
</tr>
<tr>
<td>Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>)</td>
<td>-3.26%</td>
<td>-62.74</td>
</tr>
<tr>
<td>Broadcom Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>)</td>
<td>-7.63%</td>
<td>-61.74</td>
</tr>
<tr>
<td>Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>)</td>
<td>-2.04%</td>
<td>-57.96</td>
</tr>
<tr>
<td>Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)</td>
<td>-5.80%</td>
<td>-52.76</td>
</tr>
<tr>
<td>JPMorgan Chase &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>)</td>
<td>-6.69%</td>
<td>-45.99</td>
</tr>
<tr>
<td>Bank of America Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>)</td>
<td>-9.93%</td>
<td>-31.60</td>
</tr>
</tbody>
<tfoot>
<tr>
<td>Total</td>
<td></td>
<td>-1043.67</td>
</tr>
</tfoot>
</table>
</figure>
The S&amp;P 500 fell nearly 4%, poised for its worst session since September 2022, and sank to a seven-month low. Small caps took the brunt of the sell-off, with the Russell 2000 plunging over 5% and officially entering a bear market, now down more than 20% from its 2024 peak.
Fears of retaliatory action from key U.S. trading partners dragged every major sector into the red, except for defensive plays like consumer staples and utilities.
Consumer discretionary stocks were slammed. Apparel names posted double-digit losses: Ralph Lauren Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RL#NYSE">RL</a>), Nike Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>), Lululemon Athletica Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) and Garmin Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GRMN#NYSE">GRMN</a>) each dropped between 10% and 16%.
Cruise lines were also hit hard: Norwegian Cruise Holdings Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NCLH#NYSE">NCLH</a>) sank 13%, Carnival Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCL#NYSE">CCL</a>) fell 10%, and Royal Caribbean Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCL#NYSE">RCL</a>) slid 9%.
Bond markets saw a mild flight to safety. Treasury yields edged lower, yet the U.S. dollar weakened 1.6%, with the DXY index heading for its worst day since November 2022.
Commodities weren't spared. Oil prices nosedived on fears of a global slowdown, worsened by OPEC+'s surprise move to raise output. West Texas Intermediate crude plunged 7.5%, slipping below $70 per barrel.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) showed relative resilience in the carnage, dipping just 1% and holding above $81,600.
<h1 class="wp-block-heading">Thursday&#8217;s Performance in Major U.S. Indices, ETFs</h1>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day %chg</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>40,908.76</td>
<td>-3.1 %</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,449.64</td>
<td>-3.9%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>18,751.99</td>
<td>-4.2%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>1,929.91</td>
<td>-5.6%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 12:00 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">Benzinga Pro</a>&nbsp;data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) fell 3.6% to $544.20.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) tumbled 3% to $409.26.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;plummeted 4.2% to $456.21.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) nosedived 5.4% to 191.63.</li>
<li>The&nbsp;Consumer Staples&nbsp;Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>) outperformed, up 1.2%; the&nbsp;Technology&nbsp;Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>) tanked, down 5.6%.</li>
</ul>
<h1 class="wp-block-heading">Other Major Stock, ETFs Moves To Know</h1>
<ul>
<li>Lamb Weston Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LW#NYSE">LW</a>) up 7.8%</li>
<li>Five Below Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVE#NASDAQ">FIVE</a>) down 26%,</li>
<li>Molina Healthcare Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOH#NYSE">MOH</a>), up 7.8%</li>
<li>Kohls Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KSS#NYSE">KSS</a>) down 25%</li>
<li>VanEck Vietnam ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VNM#NYSE">VNM</a>) down 10.2%</li>
<li>iShares MSCI Mexico ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EWW#NYSE">EWW</a>) up 4.7%, </li>
<li>iShares MSCI Taiwan ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EWT#NYSE">EWT</a>) down 4%. </li>
</ul>
Read Now: 
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/04/44629640/us-services-sector-slows-sharply-as-hiring-drops-tariff-pressures-mount">US Services Sector Slows Sharply As Hiring Drops, Tariff Pressures Mount</a></li>
</ul>
Photo: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Equities

Macro Economic Events

Regulations

Sector ETFs

Broad U.S. Equity ETFs

Emerging Markets

Emerging Market ETFs

Commodities

Econ #s

Economics

Tech

ETFs

$BTC

AAPL

SPDR Dow Jones Industrial Average ETF Trust

GOOGL

GRMN

LULU

MSFT

NCLH

NVDA

TSLA

Select Sector SPDR-Consumer Discretionary

Comments

Definitive Healthcare

空売り

Definitive Healthcare (NASDAQ:DH) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル